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Abstract: Bioreducible, cationic linear poly(amino ether)s (PAEs) were designed as promising gene
vectors. These polymers were synthesized by the reaction of a disulfide-functional monomer,
N,N′-dimethylcystamine (DMC), and several different diglycidyl ethers. The resulting PAEs displayed
a substantial buffer capacity (up to 64%) in the endosomal acidification region of pH 7.4–5.1.
The PAEs condense plasmid DNA into 80–200 nm sized polyplexes, and have surface charges
ranging from +20 to +40 mV. The polyplexes readily release DNA upon exposure to reducing
conditions (2.5 mM DTT) due to the cleavage of the disulfide groups that is present in the main chain
of the polymers, as was demonstrated by agarose gel electrophoresis. Upon exposing COS-7 cells
to polyplexes that were prepared at polymer/DNA w/w ratios below 48, cell viabilities between
80–100% were observed, even under serum-free conditions. These polyplexes show comparable or
higher transfection efficiencies (up to 38%) compared to 25 kDa branched polyethylenimine (PEI)
polyplexes (12% under serum-free conditions). Moreover, the PAE-based polyplexes yield transfection
efficiencies as high as 32% in serum-containing medium, which makes these polymers interesting for
gene delivery applications.
Keywords: cationic polymers; epoxy-amine reaction; bioreducible; gene delivery; disulfides;
poly(amino ether)s
1. Introduction
Non-viral gene vectors are extensively sought after to deliver DNA as therapeutic agents
to treat or cure genetic disorders [1–7]. The revolutionary advancement of CRISPR/Cas gene
editing techniques has especially inspired renewed interest in the development of safe gene
delivery agents [8–10]. Moreover, numerous non-viral vectors are able to deliver proteins which
is a crucial step in the CRISPR/Cas process [11,12]. Several properties are required to render
vectors attractive for gene delivery, such as high transfection efficiency, minimal or non-toxicity,
and ease of manufacturing [13–15]. Cationic polymers are interesting candidates that are designed
to meet these conditions, using modern developments in polymer chemistry [16–19] as well as
nanotechnology [20–22]. These polymers spontaneously form polyplexes with DNA tightly packed
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inside by means of electrostatic interactions [23–26]. These interactions are aided by the release of
sodium ions upon condensation through multivalent, polycationic polymers, leading to a net entropy
increase [27–29]. After entering the cells through endocytosis, polyplexes must escape from the
endosomal-lysosomal pathway and unpack the DNA in the cell nucleus in order to initiate gene
expression [30–33]. The cationic nature of the polymers, which is often due to the incorporation of
amine moieties, promotes endosomal escape by means of the proton sponge effect [34].
Many approaches were proposed to facilitate DNA unpacking, such as the use of acid-labile
cationic polymers [35,36], ester-based cationic polymers [37,38], and biologically triggered cationic
polymers [39–42]. Among these approaches, the latter approach is arguably the most interesting since it
takes advantage of intracellular enzymes or related biomolecules [43,44]. Glutathione, an enzyme-related
antioxidant that dictates the reductive potential of cells, is more concentrated inside the cells compared
to the extracellular environment, which thereby increases the intracellular reductive potential [45–47].
Through the introduction of disulfide-linkages in cationic polymers, this higher reductive potential
has been utilized as a trigger to cleave the disulfide bonds and unpack DNA from their polyplexes
after the successful endosomal escape of the polyplexes into the cytosol [48–50].
The introduction of disulfide moieties was successfully employed in polyethylenimine
(PEI) [51–55], poly(L-lysine) (PLL) [56,57], peptides [58,59], and poly(amido amine) dendrimers [60],
resulting in increased gene transfection and improved biocompatibility. Green and coworkers
reported cationic poly(amino ester)s with disulfides along the backbone for efficient gene
delivery [61]. Our group, as well as other groups, reported on disulfide-linked linear and branched
poly(amido amine)s that display excellent transfection efficiency and biocompatibility [62–65].
However, the clinical application of these polymers has so far been restrained due to their impaired
transfection in the presence of serum [22,66]. The introduction of hydrophilic poly(ethylene glycol)
(PEG) onto these vectors was found to increase the serum tolerance of these polymers to a limited extent,
however they still failed to meet the requirements for clinical application [66,67]. Non-degradable
poly(amino ether)s (PAEs), which are cationic polymers that bear ether groups that are similar to
those of PEG, were shown to be effective gene delivery agents, however their serum tolerance was not
investigated [68].
Here, we report a modular synthetic approach to generate disulfide-linked PAEs through the
polyaddition of N,N′-dimethylcystamine (DMC) as a bifunctional diamine monomer, and through
a series of diglycidyl ethers as epoxy monomers. The resulting bioreducible PAEs with structural
varieties in the main polymer chain, will be evaluated for cell viabilities and transfection efficiencies.
2. Results and Discussion
2.1. Polymer Preparation and Characterization
Cystamine is an interesting building block for biologically applied polymers, since its disulfide
moiety renders the resulting polymers redox responsive. However, in combination with diglycidyl
ethers, it may form branched or crosslinked structures due to the twofold reactivity of each of the
primary amines [69,70]. The resulting structures suffer from poor water solubility, which impedes
their application as gene vectors. In order to form linear polymers that are derived from cystamine
disulfide, N,N′-dimethylcystamine disulfide (DMC), a cystamine analogue in which both amine groups
are monomethylated was employed as the bifunctional amine monomer. The reaction of this amine
with a series of diglycidyl ethers with structural variations yields water-soluble bioreducible linear
poly(amino ether)s (PAEs) that are designed to be well applicable for efficient gene delivery (Scheme 1).
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Scheme 1. The modular synthesis of bioreducible poly(amino ether)s through the amine-epoxide
reaction of N,N′-dimethylcystamine (DMC) with different diglycidyl ethers.
The set of diglycidyl ethers (DEs) consists of six different molecules, as depicted in Scheme 1.
These are classified into three monomer groups: (i) high charge density (1); (ii) additional bioreducible
linker (2); and (iii) varying hydrophobicity (3–6). All three factors are rationalized to play a role in
the transfection performance of the cationic polymers. From these DEs, linear cationic PAEs were
prepared by stirring the disulfide-containing diamine DMC with the corresponding diglycidyl ethers
in the presence of excess triethylamine. The mixtures typically became homogenous after a couple
of hours and subsequently became viscous, indicating the formation of polymers. No occurrence of
gelation during the polymerization was observed, which indicated the formation of linear polymers.
After removal of impurities and small oligomers through dialysis, the polymers were obtained in
appreciable yields (ca. 14–45%). All of the polymer structures were validated by 1H NMR spectroscopy
(see Figures S1–S6 in the supplementary information). No residual epoxide signals were observed in all
cases. Molecular weights of the polymers were determined through size exclusion chromatography (SEC)
and ranged from 2.5 kDa to 4.2 kDa, with polydispersities between 1.5–2.0 (summarized in Table 1).
Table 1. Characteristics of linear bioreducible poly(amino ether)s prepared through the reaction of
N,N′-dimethylcystamine (DMC) with different diglycidyl ethers (1–6).





DMC1 31.6 3.3 1.6 4.6 36.0
DMC2 33.2 4.0 2.0 4.4 50.4
DMC3 16.9 2.5 1.5 3.8 64.0
DMC4 13.9 2.9 1.7 4.1 34.4
DMC5 43.7 3.8 1.8 5.0 53.6
DMC6 40.1 4.2 1.8 6.1 36.8
a Isolated polymer yield; b determined by size exclusion chromatography (SEC); c determined by titration, pH range
5.1–7.4.
The obtained PAEs contain tertiary amines in their main chain that are prone to protonation
in acidic milieu. Protonation not only grants the necessary positive charge to condense DNA into
polyplexes, it also provides a buffer capacity to facilitate the endosomal escape of polyplexes through
the proton sponge effect [34]. To evaluate the capacity of these polymers to accept protons in the
endosomal acidification range (pH 7.4–5.1), titration experiments were performed. The titration curves
for all PAEs are displayed in Figure 1, including the titration of reference component 25 kDa branched
PEI, a commonly employed transfection agent, and blank NaCl solution (0.15 M). Plateaus along
the titration curves in the pH 5.1–7.4 region are observed for all PAEs, which implies that there are
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pronounced buffer capacities. These buffer capacities range from 34% up to 64%, and are superior over
PEI (18%). High buffer capacity of polymers is an excellent property to enhance endosomal escape
which is necessary for the efficient gene delivery into the cytosol.Polymers 2018, 10, x FOR PEER REVIEW  4 of 14 
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Figure 1. Titration curves of poly(amino ether)s by NaOH (0.1 M) from pH 2–12. PEI (branched, 25 kDa)
and NaCl (150 mM) are included as references.
2.2. Polyplex Formation and Characterization
For efficient transfection, naked DNA requires protection by vectors, which can be realized
by forming polyplexes through electrostatic interaction between DNA and cationic polymers [71].
Here, polyplexes were prepared by combining polymer solutions of DMC1-6 and DNA solutions at
polymer/DNA mass ratios of 6, 12, 24, and 48. The resulting size and surface charge of the obtained
polyplexes at these ratios are displayed in Figure 2. The polyplexes that were formed at polymer/DNA
ratios above 6 exhibit hydrodynamic sizes from 80 to 200 nm and zeta-potentials from +20 to +40 mV.
With increasing polymer/DNA mass ratios, the polyplexes become smaller in dimension and carry
increased positive charge, corresponding to more tightly packed polyplexes and an increased number
of cationic PAEs incorporated in the formation of these polyplexes [23,26,72]. Polyplexes formed
at a polymer/DNA mass ratio of 6 display a relatively large size (over 400 nm) and an average
surface charge of +15 mV, which indicates a rather loose structure. Polyplexes prepared from DMC1
and DMC2 have a relatively small size compared to other polymers at the same polymer/DNA
ratios. This phenomenon is related to the higher cationic density of polymer DMC1, which bears
additional amine groups, resulting in increased electrostatic interaction with DNA. The additional
disulfide content of polymer DMC2 makes this polymer more flexible along the main chain, since the
disulfide bond has a low rotational barrier, which also leads to more compact polyplexes. The other
four polymers DMC3, DMC4, DMC5, and DMC6 form polyplexes with similar values in size and
zeta-potential at identical polymer/DNA mass ratios, and no clear relation can be drawn between the
polymer structure and the characteristics of the polyplexes here.
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The stability of the polyplexes under normal and reductive conditions was validated through
agarose gel electrophoresis experiments, and results are shown in Figure 3. When untreated polyplexes
(w/w = 48) that were dissolved in a HEPES buffer were subjected to electrophoresis, DNA bands
did not migrate along the electric field, indicating that DNA was fully retained by the cationic PAEs.
However, it is expected that due to the relatively high intracellular concentration of glutathione
(GSH, 2.5–10 mM), the disulfides in the polymer chain can be cleaved resulting in the disassembly
of the polyplexes and the release of the DNA content. This biological reaction was mimicked by
the incubation of the polyplexes with dithiothreitol (DTT, 2.5 mM) as a reducing agent for 30 min
under ambient conditions. These polyplexes displayed clear bands migrating along the electric force
direction, similarly to free DNA, illustrating the release of DNA from the degraded polyplexes.
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2.4. Transfection Efficiency
After the evaluation of the polyplex toxicity, the transfection performance of the polyplexes
at polymer/DNA ratios 6 and 12 was investigated on COS-7 cells using green fluorescent protein
(GFP) as a reporter gene. Three different serum conditions of 0%, 10%, and 25% were evaluated.
In all experiments, PEI polyplexes at the same polymer/DNA ratios were included as a reference.
Transfection efficiency was quantified by flow cytometry and was reported as the percentage of
GFP-expressing cells of the total population (results are shown in Figure 5). Under serum-free
conditions, the transfection efficiencies of the polyplexes prepared from PAEs at a polymer/DNA
ratio of 6 were similar or enhanced (12–25%) compared to PEI (12.1%). The transfection efficiency
increased at polymer/DNA ratio 12, reaching the highest efficiency of 36% for polyplexes based on
DMC2. Relatively low transfection efficiencies were observed for DMC1, DMC4, and DMC6. This is
most likely related to their lower buffer capacities as compared to polymers DMC2, DMC3, and DMC5.
At polymer/DNA ratio 6, the transfection efficiencies of DMC2, DMC3, and DMC5 were 25 ± 5.9%,
20 ± 2.2%, and 21 ± 2.8%, respectively, which increased to 36 ± 5.1%, 27 ± 4.0%, and 29 ± 3.4%,
respectively at a polymer/DNA ratio of 12.
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Figure 5. Transfection efficiencies of polyplexes prepared from bioreducible PAEs DMC1-6 and plasmid
DNA at polymer/DNA mass ratios of 6 (left) and 12 (right). PEI is included as a reference at its optimal
ratio of N/P = 10 in both graphs. COS-7 cells were exposed to polyplexes for 1 h and were incubated
using various serum concentrations for 2 days. Transfection efficiency was quantified using FACS.
As illustrated in Figure 5, the PAEs remained efficient in transfecting COS-7 cells, with efficiencies
ranging from 10–32% at 10% serum and 10–28% at 25% serum, which is considerably better than that
of PEI (2.5% at 10% serum and 1.0% at 25%). This effect of decreased transfection efficiency under
serum-present conditions is consistently reported in literature, for example employing poly(amino
ester)s [74], poly(amido amine)s [62], and several methacrylate-based cationic polymers [75].
The retained transfection of PAEs in the presence of serum is related to the hydroxyl groups that
are present on the polymers causing a protein repelling effect, similar to polyethylene glycol [76].
A similar effect was reported for hydroxyl-functionalized methacrylates, where the addition of
hydroxyls resulted in polyplex shielding against the serum, which was attributed to the formation
of hydroxyl-DNA hydrogen bonding [77]. The transfection efficiency of DMC2-based polyplexes
at a polymer/DNA mass ratio of 12 in the presence of 25% serum is 32%, and this is even further
enhanced to 50% for polyplexes with a polymer/DNA mass ratio of 24 with a cell viability of up to
85% (data not shown). These results underline the high potential of these disulfide-based PAEs for
non-viral gene delivery.
3. Materials and Methods
Epichlorohydrin (≥98%, Sigma-Aldrich, St. Louis, MO, USA), 2-hydroxyethyl disulfide (technical
grade, Sigma-Aldrich), tetrabutylammonium bromide (TBAB,≥98%, Sigma-Aldrich), sodium hydroxide
(NaOH, pellets, Sigma-Aldrich), 1,3-benzenedimethanol (98%, Sigma-Aldrich), N,N′-dimethylethylene
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diamine (>97.0%, TCI Europe N.V., Zwijndrecht, Belgium), 1,4-butanediol diglycidyl ether
(≥95%, Sigma-Aldrich), 1,4-cyclohexanedimethanol diglycidyl ether (3, Sigma-Aldrich), neopentyl
glycol diglycidyl ether (4, Sigma-Aldrich), branched polyethylenimine (PEI, Mw 25 kDa,
Sigma-Aldrich), dithiothreitol (DTT, Sigma-Aldrich), triethylamine (TEA, ≥99%, Sigma-Aldrich),
borane dimethyl sulfide complex (BMS, Sigma-Aldrich), N,N′-bis(2-hydroxylethyl) ethylenediamine
(>95.0%, TCI Europe N.V., Zwijndrecht, Belgium), di-tert-butyl dicarbonate (>95.0%, TCI Europe N.V.),
and thiazolidine (98%, ACROS Organics) were used as received. The water used in these experiments
was treated through a Milli-Q Gradient System (Millipore, Bedford, MA, USA). Plasmid DNA and
plasmids pCMV-GFP and pCMV-∆GFP, were purchased from a Plasmid Factory (Bielefeld, Germany).
1H NMR and 13C NMR were recorded on a Bruker NMR spectrometer (400 MHz) in
deuterated solvents. The molecular weights were determined by size exclusion chromatography
(SEC, Waters Alliance 2695) relative to PEG standards, using a Mixed-M column (PL-aquagel-OH
8 micron, 300 × 7.5 mm) with N,N-dimethylformamide containing LiCl (50 mM) as a mobile phase.
3.1. The Synthesis of N,N′-Dimethylcystamine (DMC)
The monomer was synthesized in its HCl salt form following our previous report [78].
Then, into a solution of thiazolidine (5.0 g, 56 mmol) in anhydrous tetrahydrofuran (THF, 20 mL)
under a nitrogen atmosphere, borane dimethyl sulfide complex (BMS, 10.6 g, 140 mmol) in anhydrous
THF (20 mL) was slowly added under stirring, and the mixture was subsequently refluxed overnight.
After cooling down to the ambient temperature, methanol (20 mL) was added by syringe to neutralize
any residual BMS, and the mixture was refluxed for an additional 3 h. After cooling down to the
ambient temperature, the solution was purged with HCl gas, and the mixture was concentrated under
reduced pressure. The resulting liquid was consecutively dissolved in methanol (5.0 mL) and was
precipitated twice in diethyl ether (50 mL) to obtain a white oily precipitate. The precipitate was
dissolved in water (7.5 mL) and was titrated with saturated I2/KI solution until a persistent yellow
color was obtained. After stirring for an additional 2 h, the yellow solution turned colorless upon
raising the pH to 10. The solution was extracted with chloroform (4 × 30 mL). Afterwards, the organic
fractions were combined, dried over MgSO4, and were concentrated under reduced pressure to yield
a clear liquid. Subsequently, the liquid was dissolved in isopropanol (20 mL) and was purged with
HCl gas, yielding a turbid yellow mixture and a white precipitate. The precipitate was filtered off,
washed with cold diethyl ether, and was finally recrystallized from isopropanol/methanol to obtain the
HCl salt as a white solid. (2.12 g, 30.0% yield). 1H NMR (D2O, 400 MHz): δH 2.76 (s, 6H, CH2NHCH3),
3.05 (t, 4H, SCH2CH2), 3.44 (t, 4H, SCH2CH2). 13C NMR (D2O, 400 MHz): δC 31.92, 32.83, 47.02.
3.2. The Synthesis of N,N′-bis(2-hydroxyethyl)-N,N′-bis(tert-butoxycarbonyl) ethylenediamine
Di-tert-butyl dicarbonate (17.6 g, 40 mmol) in dichloromethane (200 mL) was added dropwise
under stirring at 0 ◦C to a mixture of N,N′-bis(2-hydroxylethyl) ethylenediamine (6.00 g, 40.0 mmol)
and triethylamine (14.0 mL, 10.2 g, 100 mmol) in dichloromethane (100 mL). The mixture was stirred at
the ambient temperature overnight. The solvent was removed under reduced pressure. The resulting
solid was washed with ethyl acetate and diethyl ether and was subsequently dried under vacuum to
yield a white solid (11.2 g, 80.4% yield). 1H NMR (CDCl3, 400 MHz): δH 1.45 (s, 18H), 3.25–3.60 (m, 8H),
3.71–3.82 (m, 4H).
3.3. The Synthesis of Diglycidyl Ethers
Diglycidyl ether monomers were synthesized via the reaction of epichlorohydrin with the
corresponding diols. A typical example of the Boc-protected form of 1 (Boc-1) was: into a mixture
of N,N′-bis(2-hydroxyethyl)-N,N′-bis(tert-butoxycarbonyl) ethylenediamine (1.75 g, 5.00 mmol),
sodium hydroxide (0.800 g, 20.0 mmol), and tetrabutylammonium bromide (12.37 mg, 34.8 µmol),
epichlorohydrin (1.45 mL, 18.4 mmol) was added gradually. The mixture was heated to 40 ◦C and
was stirred for 3 h. The resulting mixture was subjected to column chromatography to obtain the
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diglycidyl ether of Boc-1 (1.95 g, 84.7% yield). 1H NMR (CDCl3, 400 MHz): δH 1.46 (s, 18H), 2.57 (s, 2H),
2.76 (t, 2H), 3.10 (m, 2H), 3.36 (m, 10H), 3.60 (m, 4H), 3.72 (m, 2H). 13C NMR (CDCl3, 400 MHz): δ 28.43,
44.12, 46.13, 47.34, 50.75, 69.89, 71.76, 79.76, 155.41.
Diglycidyl ether of 5 (1.12 g, 89.5 % yield). 1H NMR (CDCl3, 400 MHz): δH 2.62 (m, 2H, epoxide
ring OCHHCHO), 2.81 (m, 2H, epoxide ring OCHHCHO), 3.20 (m, 2H, epoxide ring OCHHCHO),
3.45 (m, 2H, CHCHHO), 3.78 (m, 2H, CHCHHO), 4.59 (m, 4H, OCH2-phenyl ring), 7.27–7.36 (m, 4H,
phenyl ring). 13C NMR (CDCl3, 400 MHz): δC 44.36, 50.93, 71.01, 73.27, 127.13, 128.64, 138.22.
3.4. The Synthesis of Poly(amino ether)s
Poly(amino ether)s (PAEs) were synthesized by the ring open polymerization of bifunctional
epoxide monomers with equimolar amounts of primary amines. A typical procedure is given for the
synthesis of DMC1:
Into a glass vial, diglycidyl ether Boc-1 (0.461 g, 1.00 mmol), DMC (0.254 g, 1.00 mmol),
triethylamine (0.400 mL, 2.87 mmol), and ethanol (0.500 mL) were charged. After 3 d stirring under
ambient temperature, the resulting viscous mixture was diluted with methanol (50.0 mL) and purged
with HCl gas for 30 min in order to remove the Boc protecting groups. The mixture was concentrated,
and the residue was dissolved in water (15.0 mL), acidified with 4 M HCl solution to pH 4, and was
purified via dialysis (MWCO 1 kDa) against water overnight. Polymer DMC1 was obtained after
lyophilization as an amorphous solid. The other PAE polymers DMC2-6 were synthesized analogously,
however these polymers do not require the Boc removal step.
Polymer DMC1 (off-white solid, 0.162 g, 31.6%): 1H NMR (D2O, 400 MHz): δH 2.98 (s, 6H,
NCH3), 3.10–3.16 (m, 4H, CH2NHCH2CH2O), 3.26 (m, 4H, NCH2CH2S), 3.32–3.38 (b, 8H,
CH2NHCH2CH2O + OCH2CHOHCH2NCH2CH2S), 3.35–3.64 (m, 8H, CH2OCH2), 3.79 (t, 4H,
OCH2CHOHCH2NCH2CH2S), 4.30 (bs, 2H, OCH2CHOHCH2NCH2CH2S).
Polymer DMC2 (white solid, 0.132 g, 33.2%): 1H NMR (D2O, 400 MHz): δH 2.95 (s, 6H,
NCH3), 2.96 (m, 4H, OCH2CH2S), 3.09–3.14 (m, 4H, NCH2CH2S), 3.30 (m, 4H,
CH2OCH2CHOHCH2NCH2CH2S), 3.55–3.65 (m, 8H, CH2OCH2CHOHCH2NCH2CH2S), 3.80–3.89 (m,
4H, OCH2CH2S), 4.25 (bs, 2H, CH2OCH2CHOHCH2NCH2CH2S).
Polymer of DMC3 (white solid, 0.086 g, 16.9% yield): 1H NMR (D2O, 400 MHz): δH
0.90–1.01 and 1.75–1.79 (m, 8H, 4 × CH2 of cyclohexane ring), 1.29 and 1.49 (m, 2H, CH
of cyclohexane ring), 2.98 (s, 6H, NCH3), 3.11–3.18 (m, 4H, NCH2CH2S), 3.20–3.31 (m, 4H,
CH2OCH2CHOHCH2NCH2CH2S), 3.37–3.47 (m, 4H, CH2OCH2CHOHCH2NCH2CH2S),
3.51–3.67 (m, 8H, CH2OCH2CHOHCH2NCH2CH2S), 4.25 (bs, 2H, CH2OCH2CHOHCH2NCH2CH2S).
Polymer DMC4 (amorphous solid, 0.064 g, 13.9% yield): 1H NMR (D2O, 400 MHz): δH 0.91 (s, 6H,
C(CH2CH3)2), 2.92 (s, 6H, NCH3), 3.08–3.12 (m, 4H, NCH2CH2S), 3.26–3.32 (m, 8H, C(CH2CH3)2
+ CH2OCH2CHOHCH2NCH2CH2S), 3.66–3.75 (m, 8H, CH2OCH2CHOHCH2NCH2CH2S),
4.25 (bs, 2H, CH2OCH2CHOHCH2NCH2CH2S).
Polymer of DMC5 (white solid, 0.220g, 43.7%): 1H NMR (D2O, 400 MHz): δH 2.96 (s, 6H, NCH3),
3.09–3.12 (m, 4H, NCH2CH2S), 3.24–3.30 (m, 4H, phenyl ring-CH2OCH2CHOHCH2NCH2CH2S),
3.57–3.64 (m, 8H, phenyl ring-CH2OCH2CHOHCH2NCH2CH2S), 4.26 (bs, 2H, phenyl
ring-CH2OCH2CHOHCH2NCH2CH2S), 4.62–4.65 (m, 4H, phenyl ring-CH2OCH2CHOHCH2NCH2CH2S),
7.40–7.45 (m, 4H, phenyl ring).
Polymer of DMC6 (amorphous solid, 0.183 g, 40.1% yield): 1H NMR (D2O, 400 MHz): δH 1.63 (bs, 4H,
OCH2CH2CH2CH2O), 2.96 (s, 6H, NCH3), 3.04–3.13 (m, 4H, NCH2CH2S), 3.23–3.30 (m, 4H,
CH2OCH2CHOHCH2NCH2CH2S), 3.52–3.62 (m, 12H, CH2OCH2CHOHCH2NCH2CH2S), 4.25 (bs, 2H,
CH2OCH2CHOHCH2N).
3.5. Buffer Capacity Titration
Buffering capacities of the polymers were determined via acid-base titration. The amount of
PAE polymer equal to 5 mmol protonable amine groups was dissolved in NaCl aqueous solution
Polymers 2018, 10, 687 9 of 14
(150 mM, 10 mL). The pH of the polymer solution was acidified to ≤2.0 and the solution was titrated
with NaOH solution (0.1 M) using an automatic titrator (Metrohm 702 SM Tirino). As a reference,
b-PEI (25 kDa) and NaCl aqueous solution were titrated following the same method. The percentage of
amine groups protonated from pH 5.1 to 7.4 was defined as the buffer capacity that can be calculated
from the following equation [79]:
buffer capacity (%) =
∆VNaOH × 0.1 M
N mole
× 100% (1)
wherein, ∆VNaOH denotes the NaOH volume that is required to bring the pH value of the polymer
solution from 5.1 to 7.4, and N mole (5 mmol) denotes the total moles of protonable amine groups in
the PAE polymer.
3.6. Polyplex Preparation
Polyplexes were prepared by adding polymer solution into the DNA solution at designated
polymer/DNA mass ratios. All polymer and DNA solutions were prepared in the HEPES buffer
(20 mM, pH 7.4). The procedure of polyplexes prepared at the mass ratio of 48 is as follows:
In an Eppendorf tube (1.5 mL), DNA solution (75 µg/mL, 200 µL) and polymer solution
(900 µg/mL, 800 µL) were successively added. The mixture was subjected to vortexing for 5 s
and was incubated at room temperature for 30 min to obtain the polyplex suspensions. The size
and surface charge of the polyplexes were measured on a Zetasizer Nano ZS (Malvern Instruments,
Malvern, UK) at 25 ◦C. The data present the means of the three measurements with the corresponding
standard deviations as error bars.
3.7. Agarose Gel Electrophoresis
Polyplexes were prepared at a polymer/DNA mass ratio of 48, as described in the previous
protocol. Polyplex solutions (90 µL) were diluted with either DTT HEPES solution (25 mM, 10 µL)
or HEPES buffer (10 µL), and were incubated under ambient conditions for 30 min. The resulting
dispersions (20 µL) were mixed with 6× loading buffer containing bromophenol (Ferments, 5.0 µL)
and were aliquoted (10 µL) to load on agarose gel (0.8% w/v) containing 1× SYBR® Safe DNA
Gel Stain (Invitrogen™, Carlsbad, CA, USA). The gel was developed at 90 V for 60 min in a TBE
(Tris-borate-EDTA, 1×) running buffer and was consecutively imaged via FluorChem (Proteinsimple,
Westburg, Leusden, The Netherlands) under UV excitation.
3.8. Cytotoxicity
The cytotoxicity of polyplexes towards COS-7 cells was evaluated through MTT assays. In 96 well
plates, ca. 104 cells were seeded per well and were allowed to grow overnight in complete medium
(100 µL, DMEM medium supplemented with 10% FBS) at 37 ◦C under 5% CO2 conditions to reach
60–80% confluency. The medium was replaced with fresh medium (100 µL, w/o 10% FBS). After 30 min
of incubation, the cells were loaded with either polyplex solutions at various polymer/DNA mass
ratios (100 µL, 0.25 µg DNA per well) or HEPES buffer (20 mM, pH 7.4, supplemented with 5.0 wt %
glucose) and were incubated for an additional 1 h. All cells were refreshed with complete warm
culture medium (100 µL) and were cultured for another 48 h. Half of the cells that were untreated
with polyplexes were killed by incubating in 100× triton (4%, 10 µL) for 15 min, while the residual
half were taken as a control to set the viability to 100%. All of the cells were washed with DPBS
(100 µL) and were successively incubated in MTT solution (0.5 mg/mL, 100 µL) at 37 ◦C under 5%
CO2 condition for 4 h. After refreshing MTT with DMSO (100 µL), the resultant formazone crystals
were quantified through a plate reader (Tecan Infinite M200) at wavelength 540 nm with reference
680 nm. Measurements were performed in triplicate.
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3.9. Transfection Efficiency
The plasmids of pCMV-GFP and pCMV-∆GFP were respectively used as positive and negative
controls. In 48 well plates, the cells were seeded at a density of 1.6 × 104 per well (1.6 × 104 cells/cm2)
and were cultured in complete medium (DMEM with 10% FBS, 200 µL) at 37 ◦C under humidified
atmosphere with 5% CO2 to reach confluencies of 60–80%. The cells were refreshed with warm medium
(200 µL) with designated serum concentration and were maintained in new medium for 30 min until
they were finally treated with polyplex solutions (200 µL, 0.5 µg DNA per well). After 60 min of
incubation at 37 ◦C, the polyplexes were replaced with fresh warm complete medium (200 µL), and the
cells were allowed to grow for another 48 h. After replacing the old medium with trypsin solution
(0.25%, 200 µL), the cells were spun down (600 g, 5 min, R.T.), resuspended in HBSS buffer (200 µL),
and were measured by the FACSCalibur (Becton-Dickinson, Breda, The Netherlands) at an excitation
wavelength of 488 nm and emission at 530 nm. FACS Cellquest Software was applied to process the
data. A 25 kDa branched PEI/DNA formulation, prepared at its recommended ratio of N/P = 10,
was used as a reference.
4. Conclusions
A modular approach towards the incorporation of bioreducibility into linear poly(amino ether)s
was developed through the reaction of N,N′-dimethylcystamine with various diglycidyl ethers.
The obtained PAEs have good to excellent buffer capacities, ranging from 40 to 67%. Upon mixing
PAEs with DNA at appropriate mass ratios, polyplexes were formed with hydrodynamic diameters
ranging from 80–200 nm and zeta-potentials of up to +40 mV. The polyplexes displayed no significant
toxicity towards COS-7 cells at polymer/DNA ratios up to 24 with transfection of COS-7 cells with
notable efficiencies of up to 36%. In addition, the presence of serum did not markedly interfere with
the transfection efficiency, even at serum concentrations of 10% and 25%. This effect is attributed to
the presence of the protein repelling hydroxyl moieties within the PAEs. All transfection efficiencies
and biocompatibility profiles of PAE-based polyplexes outpace the common polymeric vector PEI
(branched, 25 kDa). Overall, these results present a novel modular approach towards a new generation
of easily accessible cationic polymers for gene and drug delivery.
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